Screener
Merck & Co. MRK Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Merck & Co. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The source filing: Merck & Co.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:11 PM EDT
- Fiscal quarter
- Q3 FY2028
- Calendar quarter
- Q3 2028
- Accession
- 0000310158-26-000212
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Total current liabilities | 27,731 | 28,327 |
| Long-Term Debt | 51,081 | 46,750 |
| Deferred Income Taxes | 1,433 | 1,439 |
| Other Noncurrent Liabilities | 7,573 | 7,688 |
| Merck & Co., Inc. Stockholders’ Equity | ||
| Common stock, $0.50 par valueAuthorized - 6,500,000,000 sharesIssued - 3,577,103,522 shares in 2026 and 2025 | 1,788 | 1,788 |
| Other paid-in capital | 44,950 | 45,029 |
| Retained earnings | 63,269 | 73,075 |
Item 1. Financial Statements
FAQ
- What is Merck & Co.'s other non-current liabilities?
- Merck & Co. (MRK) reported other non-current liabilities of $7.57B in Q2 2026.
- How has Merck & Co.'s other non-current liabilities changed year-over-year?
- Merck & Co.'s other non-current liabilities increased by 7.7% year-over-year, from $7.03B to $7.57B.
- What is the long-term trend for Merck & Co.'s other non-current liabilities?
- Over 5 years (2020 to 2025), Merck & Co.'s other non-current liabilities has grown at a -9.0% compound annual growth rate (CAGR), from $12.31B to $7.69B.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.
Ask your AI about Merck & Co.'s other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude